PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'CHLO, Centro Hospitalar de Lisboa Ocidental, Serviço de Patologia Clínica, Lisbon, 1449-005, Portugal.\', \'IGC, Instituto Gulbenkian de Ciência, Oeiras, 2780-156, Portugal.\', \'CIISA, Centre for Interdisciplinary Research in Animal Health, Faculty of Veterinary Medicine, University of Lisbon, Lisbon, 1300-477, Portugal.\', \'IBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, 2780-901, Portugal.\', \'ITQB NOVA, Instituto de Tecnológia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, 2780-157, Portugal.\', \'IGC, Instituto Gulbenkian de Ciência, Oeiras, 2780-156, Portugal. cpenha@igc.gulbenkian.pt.\', \'IGC, Instituto Gulbenkian de Ciência, Oeiras, 2780-156, Portugal. jocelyne@igc.gulbenkian.pt.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41467-021-27761-z
?:doi
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 35013258
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
?:title
  • Population homogeneity for the antibody response to COVID-19 BNT162b2/Comirnaty vaccine is only reached after the second dose across all adult age ranges.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35013258>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35013258>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all